HR Execs on the Move

Covance

www.covance.com

 
As the drug development business of Laboratory Corporation of America Holdings (LabCorp) and the world’s most comprehensive drug development service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.covance.com
  • 210 Carnegie Center
    Princeton, NJ USA 08540
  • Phone: 609.452.4440

Executives

Name Title Contact Details
Jill McConnell
 Senior VP & Chief Financial Officer Profile
Anne Haumacher
 Director of Global Commercial Training and Development Profile
Rhonda Holler
 Vice President of Global Talent Management Profile
Lyn Challis
 Vice President - Human Resources - Clinical Development Services Profile
Lyn Challis
 Vice President, Human Resources, Clinical Development Services Profile

Similar Companies

Better Health Group

Better Health Group is a national primary care platform that enables providers to shift focus to value-based care. They take a proactive approach by focusing on preventing disease rather than just treating symptoms.

CCBR-SYNARC

Synarc enables its clients to demonstrate the efficacy of new therapies across a broad range of therapeutic areas through highly specialized medical imaging and molecular marker techniques.

Cardio-Respiratory Assistance

Cardio-Respiratory Assistance is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Osseon Therapeutics

Osseon Therapeutics is a Santa Rosa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dyax Corp.

Dyax Corp. (Dyax) is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.